Product Description: Alefacept (BG 9273) is a human lymphocyte function-associated antigen 3/immunoglobulin 1 fusion protein. Alefacept can be used for the research of chronic plaque psoriasis[1].
Formula: N/A
References: [1]Mark Lebwohl, et al. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol. 2003 Jun;139(6):719-27.
CAS Number: 222535-22-0
Molecular Weight: N/A
Compound Purity: 99.75
Research Area: Others
Solubility: 10 mM in DMSO
Target: Others